Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Eye (Lond) ; 37(5): 809-814, 2023 04.
Artículo en Inglés | MEDLINE | ID: mdl-35306540

RESUMEN

Metastasis to the eye can involve the choroid (90%), ciliary body (2%), iris (8%), and retina, optic disc, vitreous, and/or lens capsule (<1-4%). The mean number of uveal metastasis per eye (1.7), mean tumour base (11.6 mm) and thickness (3.2 mm), tumour colour (86% yellow), and presence of subretinal fluid (72%), are all clinical features suggestive of the diagnosis. Imaging with ultrasonography demonstrates an echodense mass (80%) and optical coherence tomography shows a "lumpy bumpy" choroidal surface (64%), both important diagnostic features. Uveal metastases typically emanate from primary cancer of the breast (37%), lung (27%), kidney (4%), gastrointestinal tract (4%), cutaneous melanoma (2%), lung carcinoid (2%), prostate (2%), thyroid (1%), pancreas (1%), and other sites (3%). Occasionally, fine needle aspiration biopsy is employed if the primary site is not known. In 16% of cases, the primary site remains unknown. Rarely, metastases affect the retina, vitreous, and lens capsule, most often originating from cutaneous melanoma and in patients previously treated with checkpoint inhibitor therapy. Kaplan-Meier analysis in a series of 1111 patients with uveal metastasis revealed 32% survival at 3 years and 24% at 5 years. Patients with uveal metastasis from carcinoid tumour showed most favourable survival at 5-years (92%), whereas pancreatic and kidney cancer demonstrated least favourable survival (0%). The 5-year survival was better for females (versus (vs.) males) (31% vs. 21%) and older adults (vs. children) (40% vs. 0%). In this review, we examine several large-cohort publications on the topic of ocular metastasis.


Asunto(s)
Melanoma , Disco Óptico , Neoplasias Cutáneas , Neoplasias de la Úvea , Masculino , Femenino , Niño , Humanos , Anciano , Melanoma/patología , Cuerpo Ciliar/patología , Neoplasias Cutáneas/patología , Neoplasias de la Úvea/diagnóstico , Disco Óptico/patología , Iris/patología , Coroides/patología , Retina/patología , Melanoma Cutáneo Maligno
2.
Ocul Immunol Inflamm ; 31(1): 123-126, 2023 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-34802374

RESUMEN

PURPOSE: The authors present a case of a 60-year-old Indian female presented with sudden loss of vision in the right eye three days after an uneventful cataract surgery which revealed a rare organism and which was treated successfully. METHODS: She was diagnosed with acute postoperative endophthalmitis with fulminant disease and on further work up, culture showed Morganella morganii (gram negative bacilli). RESULTS: She was successfully treated with intravitreal imipenem, dexamethasone and vitrectomy. A review of literature was conducted to identify and discuss additional reports on similar cases. As per PubMed search with keywords "Morganella morganii endophthalmitis" this is the best achieved visual outcome to date in a case of acute post-operative Morganella morganii endophthalmitis. CONCLUSION: Intravitreal imipenem can be considered to treat Morganella morganii endophthalmitis. Aggressive treatment in these patients can help in improving visual outcome.


Asunto(s)
Endoftalmitis , Infecciones Bacterianas del Ojo , Morganella morganii , Humanos , Femenino , Persona de Mediana Edad , Antibacterianos/uso terapéutico , Cuerpo Vítreo , Infecciones Bacterianas del Ojo/diagnóstico , Infecciones Bacterianas del Ojo/tratamiento farmacológico , Agudeza Visual , Endoftalmitis/diagnóstico , Endoftalmitis/tratamiento farmacológico , Complicaciones Posoperatorias/diagnóstico , Vitrectomía , Imipenem
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA